NCT04997317 2025-04-13
PROMENADE
University Hospital, Basel, Switzerland
Phase 1/2 Recruiting
Clinical Trials
4 trialsNCT02592707 2023-07-19
Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs
Ipsen
Phase 1/2 Terminated
NCT03773133 2022-09-13
SSTR2+
Ipsen
Phase 1/2 Terminated
NCT02609737 2022-02-01
Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors
Memorial Sloan Kettering Cancer Center
Phase NA Completed